Taken together all these observations, it is possible that IFNG along with other genes implicated in the inflammatory response may contribute to the development of the high-grade systemic inflammation status seen in RA patients that could explain the increased CV morbidity and mortality reported in these patients. The gene discussed is IFNG; the disease is rheumatoid arthritis.